Food, Health & Wellness News
-
FinCanna Announces Final Upsize to Convertible Debenture Financing to total $4.5 Million
February 4, 2019 (Source) — Second Tranche of $2.1 Million Scheduled to Close on or before February 8, 2019…
-
FinCanna Signs Royalty Agreement with Multi Brand Manufacturer, QVI, of Sonoma County, California
January 31, 2019 (Source) — FinCanna agrees to Royalty Financing with Infused Products Manufacturer FinCanna Capital Corp. (“FinCanna”) (CSE:…
-
FinCanna Upsizes Convertible Debenture Financing to total $4.275 Million
January 30, 2019 (Source) — FinCanna Capital Corp. (“FinCanna”) (CSE: CALI) a royalty company for the U.S. licensed medical…
-
InvestorIntel Corp.: Invitation to Cantech Investment Conference Booth 303
January 24, 2019 (Source) — InvestorIntel Corp. would like to cordially invite you to visit us at Booth #303 at…
-
NanoSphere Signs Definitive Licensing Agreement with Delta 9 Cannabis Inc.
January 24, 2019 (Source) — NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) is pleased to announce the Company has…
-
NanoSphere Announces Anti-Aging Product Using Nano-Sized Particles of Hyaluronic Acid
January 17, 2019 (Source) — NanoSphere Health Sciences, Inc. (CSE: NSHS) (OTC: NSHSF) announced today it has developed an…
-
SOL Global Investments Announces Voting Results from the Annual and Special Meeting of Shareholders
January 16, 2019 (Source) — SOL Global Investments Corp. (the “Company”) (CSE:SOL) (Frankfurt:9SB) (QTCQB:SOLCF) is pleased to announce the…
-
Kontrol Energy to Provide Emission Compliance Services to Ontario Cannabis Company
January 14, 2019 (Source) — Kontrol Energy Corp. (CSE: KNR, FSE: 1K8), (“Kontrol” or the “Company”) through its operating…
-
FinCanna Increases and Closes Convertible Debenture Financing of $2.4 Million
January 11, 2019 (Source) — Additional 2nd Tranche of $1.25 Million Scheduled to Close on or before February 8,…
-
NanoSphere Partners with Gofire to Debut DoseCode-Enabled Products in Colorado Market
January 9, 2019 (Source) — Scannable Technology Grants Patients Access to Descriptions, Reviews and Dosing Information for Evolve Formulas…
